PHILADELPHIA and LONDON, Aug. 18 /PRNewswire/ --Thomson Reuters today announced that they have joined the InChI Trust, a not-for-profit organization to expand and develop the InChI Open Source chemical structure representation algorithm. The algorithm provides a consistent, credible and compatible way for databases of chemical structures to be linked together for the benefit of users of chemical information around the world.
"We are committed to supporting the InChI Trust and InChI initiative," said Dr. Josep Prous, Jr., Vice President and Chief Scientific Officer at Thomson Reuters. "The latest version of Prous Science Integrity(R) drug discovery database adds InChI's and InChIKeys to the more than 370,000 drugs and intermediates covered, facilitating access to and communication of information in the chemistry community."
Support of the InChI initiative and the adoption of InChI's within Prous Science Integrity(R) will further chemistry users' ability to integrate information across multiple sources and communicate this information in a consistent way across the globe.
"We are delighted to welcome Thomson Reuters as a member of the InChI Trust," says Project Leader Dr. Stephen Heller. "We value their support, as specialists within the chemical information industry, to continue to develop the InChI and InChIKey standards to enable wide scale linking of chemical information."
Prous Science Integrity seamlessly integrates biological, chemical and pharmacological information on more than 300,000 compounds with demonstrated biological activity, plus tens of thousands of synthesis intermediates and over 125,000 patent family records. Updated daily, this unique database is designed to empower your drug discovery and development activities. Find out more about
|SOURCE Thomson Reuters|
Copyright©2009 PR Newswire.
All rights reserved